home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Systems Biology Tackles The Mechanisms Of Cancer

  October, 13 2006 10:50
your information resource in human molecular genetics
Potential novel targets for anti-cancer therapy are revealed in a paper published online in Molecular Systems Biology. Forest White and colleagues investigated the EGFR/HER2 signaling pathway, which is perturbed in human breast cancer.

The HER2 receptor is over-expressed in several human cancers and is the target of the recently developed Herceptin therapy against metastatic breast cancer. Understanding the mechanisms relating HER2 over-expression to tumor cell proliferation and migration is key for the development of novel anti-cancer therapeutics.

The authors of the present study applied a number of high-throughput technologies and systems biology approaches to investigate the impact of high levels of HER2 receptors on intracellular signaling. Their analysis links the effects of HER2 over-expression to cell migration and reveals many potential novel anti-cancer targets. According to a related News and Views article from Mark Greene and Alan Berezov, these findings 'mark an important breakthrough' in the characterization of the EGFR signaling network in tumors.

Author contacts:

Forest M White (Massachusetts Institute of Technology, Cambridge, MA, USA)
E-mail: fwhite@mit.edu

Mark Greene (University of Pennsylvania, Philadelphia, PA, USA) N&V author
E-mail: greene@reo.med.upenn.edu
Editorial contact:

Thomas Lemberger (European Molecular Biology Organization, Heidelberg, Germany)
E-mail: thomas.lemberger@embo.org

Full Text available online.

(C) Molecular Systems Biology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.